Issued Patents All Time
Showing 26–50 of 88 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10577616 | FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | Noel Cogan, John White Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg +5 more | 2020-03-03 |
| 10563184 | Regulation of gene expression using engineered nucleases | Edward J. Rebar | 2020-02-18 |
| 10526610 | FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | Noel Cogan, John White Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg +5 more | 2020-01-07 |
| 10501748 | Methods and compositions for integration of an exogenous sequence within the genome of plants | W. Michael Ainley, Dmitry Y. Guschin, Matthew Hayden, Daniel Isenegger, John Mason +5 more | 2019-12-10 |
| 10471123 | Methods and compositions for treating Huntington's disease | Edward J. Rebar, H. Steve Zhang | 2019-11-12 |
| 10435441 | HTT repressors and uses thereof | Steven Froelich, David Paschon, Edward J. Rebar, Bryan Zeitler, H. Steve Zhang | 2019-10-08 |
| 10435677 | Genetically modified human cell with a corrected mutant sickle cell mutation | Gregory J. Cost, Lei Zhang | 2019-10-08 |
| 10407476 | Methods and compositions for treating hemophilia | David Paschon, Edward J. Rebar | 2019-09-10 |
| 10287595 | Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | W. Michael Ainley, Steven R. Webb, Jayakumar P. Samuel, Dmitry Y. Guschin, Lei Zhang | 2019-05-14 |
| 10265377 | Methods and compositions for treating Huntington's Disease | Edward J. Rebar, H. Steve Zhang | 2019-04-23 |
| 10253333 | DNA-binding proteins and uses thereof | Philip D. Gregory, David Paschon, Edward J. Rebar, Siyuan Tan, Fyodor Urnov +1 more | 2019-04-09 |
| 10081661 | Methods and compositions for genome engineering | David Paschon, Edward J. Rebar, Thomas Wechsler, Lei Zhang | 2018-09-25 |
| 10072062 | Methods and compositions for modification of a HLA locus | Trevor Collingwood, Laurence J.N. COOPER, Philip D. Gregory, Michael C. Holmes, Edward J. Rebar +2 more | 2018-09-11 |
| 10066242 | Artificial nucleases comprising engineered cleavage half-domains | Yannick Doyon | 2018-09-04 |
| 10017775 | Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis | Russell DeKelver, Manju Gupta, Stephen Novak, Joseph F. Petolino | 2018-07-10 |
| 9982245 | Compositions for linking DNA-binding domains and cleavage domains | — | 2018-05-29 |
| 9970001 | Methods and compositions for nuclease design | — | 2018-05-15 |
| 9963715 | Methods and compositions for treatment of a genetic condition | Gregory J. Cost, Philip D. Gregory, Dmitry Guschin, Michael C. Holmes, David Paschon +4 more | 2018-05-08 |
| 9963711 | FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | Noel Cogan, John White Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg +5 more | 2018-05-08 |
| 9914930 | FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks | Noel Cogan, John White Forster, Matthew Hayden, Tim Sawbridge, German Spangenberg +5 more | 2018-03-13 |
| 9783827 | DNA-binding proteins and uses thereof | Philip D. Gregory, David Paschon, Edward J. Rebar, Siyuan Tan, Fyodor Urnov +1 more | 2017-10-10 |
| 9771403 | Methods and compositions for treating hemophilia | David Paschon, Edward J. Rebar | 2017-09-26 |
| 9765361 | Engineered cleavage half-domains for generating nuclease-mediated genomic modifications in a cell | Yannick Doyon | 2017-09-19 |
| 9717759 | Modification of CXCR4 using engineered zinc finger proteins | Michael C. Holmes, Jianbin Wang | 2017-08-01 |
| 9650648 | Methods and compositions for treatment of a genetic condition | Gregory J. Cost, Philip D. Gregory, Dmitry Guschin, Michael C. Holmes, David Paschon +4 more | 2017-05-16 |